BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2277127)

  • 1. Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Schrøder H; Kragballe K
    J Clin Pharmacol; 1990 Sep; 30(9):802-7. PubMed ID: 2277127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy for psoriasis with methotrexate and etretinate.
    Tuyp E; MacKie RM
    J Am Acad Dermatol; 1986 Jan; 14(1):70-3. PubMed ID: 3950115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of etretin and etretinate during long-term treatment of psoriasis patients.
    Larsen FG; Jakobsen P; Larsen CG; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1988 Mar; 62(3):159-65. PubMed ID: 2967472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose pharmacokinetics of etretin and etretinate in psoriatic patients.
    Larsen FG; Jakobsen P; Larsen CG; Nørgaard A; Kragballe K; Nielsen-Kudsk F
    Pharmacol Toxicol; 1987 Aug; 61(2):85-8. PubMed ID: 2959917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of etretinate and acitretin with special reference to treatment of psoriasis.
    Larsen FG
    Acta Derm Venereol Suppl (Stockh); 1994; 190():1-33. PubMed ID: 7900497
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate.
    Rosenbaum MM; Roenigk HH
    J Am Acad Dermatol; 1984 Feb; 10(2 Pt 2):357-61. PubMed ID: 6707259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of erythrodermic and pustulous psoriasis with a combination of methotrexate and etretinate].
    Allegue Rodriguez F; Sendagorta Gomendio E; Freire Murgueytio P; Moreno Izquierdo R; Ledo Pozueta A
    Med Cutan Ibero Lat Am; 1988; 16(1):43-9. PubMed ID: 2967409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate and etretinate as concurrent therapies in severe psoriasis.
    Vanderveen EE; Ellis CN; Campbell JP; Case PC; Voorhees JJ
    Arch Dermatol; 1982 Sep; 118(9):660-2. PubMed ID: 7114868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
    Mom A; Aresca S; Fuente G; Pecorini V; Pellerano G; Perez V
    Acta Derm Venereol; 1982; 62(4):357-8. PubMed ID: 6183878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate and etretinate in the treatment of psoriasis.
    Vanderveen EE; Ellis CN
    Arch Dermatol; 1984 Dec; 120(12):1555-6. PubMed ID: 6508327
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent methotrexate and etretinate therapy for psoriasis.
    Adams JD
    Arch Dermatol; 1983 Oct; 119(10):793. PubMed ID: 6614945
    [No Abstract]   [Full Text] [Related]  

  • 14. Etretinate kinetics during chronic dosing in severe psoriasis.
    Massarella J; Vane F; Buggé C; Rodriguez L; Cunningham WJ; Franz T; Colburn W
    Clin Pharmacol Ther; 1985 Apr; 37(4):439-46. PubMed ID: 3979005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in prescriptions of oral medications for psoriasis: A single-center retrospective study.
    Takano-Kawasaki S; Sato E; Yamaguchi K; Imafuku S
    J Dermatol; 2023 Jan; 50(1):82-88. PubMed ID: 36229921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol.
    Larsen FG; Jakobsen P; Knudsen J; Weismann K; Kragballe K; Nielsen-Kudsk F
    J Invest Dermatol; 1993 May; 100(5):623-7. PubMed ID: 8491984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etretinate therapy improves psoriasis but elevates serum lipids.
    Cowart VS
    JAMA; 1982 May; 247(19):2647-8. PubMed ID: 7077753
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study.
    Gollnick H; Bauer R; Brindley C; Orfanos CE; Plewig G; Wokalek H; Hoting E
    J Am Acad Dermatol; 1988 Sep; 19(3):458-68. PubMed ID: 2971692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.